BioMarin Pharmaceutical has completed its acquisition of Amicus Therapeutics, buying the company for $14.50 per share in an all-cash deal.
BioMarin acquires Amicus Therapeutics for $4.8bn
BioMarin Pharmaceutical has completed its acquisition of Amicus Therapeutics, buying the company for $14.50 per share in an all-cash deal.
كشفت تقارير طبية حديثة عن وجود ارتباط واضح بين السمنة وزيادة خطر الإصابة بما يصل إلى 11 نوعًا مختلفًا من السرطان.
اختيار وجبة منتصف اليوم لا يتعلق فقط بسد الجوع، بل يلعب دورًا أساسيًا في دعم الطاقة واستمرار التركيز والحفاظ على الكتلة العضلية.
The World Health Organization says that a suspected hantavirus outbreak on a cruise ship in the Atlantic Ocean has killed three people and sickened at least …
President Trump arrived at his Doral golf resort on Sunday, as the PGA Tour returned to the venue for the first time since 2016. The president …